Insiders Abivax

Equities

Real-time Euronext Paris Other stock markets 03:26:45 2024-05-09 am EDT			5-day change	1st Jan Change
13.2 ^EUR	-1.93%		-4.49%	+34.42%

May. 08	Abivax: four abstracts to be presented on obefazimod	CF
May. 08	Abivax SA Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Preclinical Colon Cancer Model At Digestive Disease Week 2024	CI

ABIVAX Société Anonyme Appoints Ana Sharma as Global Head of Quality	Feb. 07	CI
Abivax appoints new head of quality	Feb. 07	CF
Abivax appoints head of investor relations	23-08-24	CF
Abivax SA Appoints Patrick Malloy as Senior Vice President Investor Relations	23-08-23	CI
Abivax: two appointments to the Board of Directors	23-07-12	CF
ABIVAX SociÃ©tÃ© Anonyme Announces Board Changes	23-07-11	CI
Abivax appoints new HR Director	23-06-08	CF
Abivax Appoints Ida Hatoum as Chief People Officer	23-06-08	CI
ABIVAX Société Anonyme Announces Executive Appointments	23-04-19	CI
Abivax Names New Chief Commercial Officer	23-04-19	MT
Abivax appoints Sales Director	23-04-18	CF
Abivax Société Anonyme Appoints Michael Ferguson as Chief Commercial Officer	23-04-18	CI
Abivax: new CEO appointed	23-04-06	CF
Abivax Société Anonyme Announces Board Changes	23-04-05	CI
Abivax Société Anonyme Announces CEO Changes	23-04-05	CI
Abivax Names New Chief Medical Officer	23-02-17	MT
French Biotech Abivax Chair Resigns; Interim Successor Appointed	22-08-17	MT
Abivax Société Anonyme Approval for Abx464 Phase 1 Study in Japanese Subjects for Subsequent Inclusion of Japan into the Global Phase 3 Program in Ulcerative Colitis	21-08-17	CI
Abivax Appoints Sophie Biguenet as Chief Medical Officer	21-03-02	CI
Abivax Société Anonyme Announces Management Changes	19-07-11	CI

No results for this search